My Financial News from Tabuk, Saudi Arabia

from Bing and Google News
Saudi Arabia , Thursday 15 October 2026

Saudi Arabia Pharmaceutical CDMO Market Research Report 2025 Featuring Tabuk Manufacturing, Lifera, Saudi Bio, Fresenius Kabi, Hikma Pharma, Pfizer, Novartis

Published on: Monday 12 May 2025

Saudi Arabia Pharmaceutical CDMO Market Research Report 2025 Featuring Tabuk Manufacturing, Lifera, Saudi Bio, Fresenius Kabi, Hikma Pharma, Pfizer, Novartis The Saudi Arabia Pharmaceutical CDMO Market, valued at USD 1.62 Billion in 2024, is projected to reach USD 2.24 Billion by 2030 with a CAGR of 5.45%. Growth is driven by rising domestic demand, health system modernization, and cost efficiency. Key players include Tabuk Manufacturing Company and Lifera. Saudi Arabian Pharmaceutical CDMO Market Saudi Arabian Pharmaceutical CDMO Market Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Pharmaceutical CDMO Market, By Region, Competition, For


News source: https://finance.yahoo.com/news/saudi-arabia-pharmaceutical-cdmo-market-084600388.html

Share this news on:  

RELATED NEWS

» TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA
» Saudi Arabia Pharmaceutical CDMO Market Research Report 2025 Featuring Tabuk Manufacturing, Lifera, Saudi Bio, Fresenius Kabi, Hikma Pharma, Pfizer, Novartis
» People in Saudi Arabia visit mountain to experience the cold weather
» Royal Saudi Land Forces and Egyptian Armed Forces Continue Executing 'Tabuk-5' Exercise
» Jabal Al-Lawz in Saudi Arabia's Tabuk Region Blanketed with Snow

HEADLINE NEWS